---
title: "Ocrevus (ocrelizumab), all indications: Access and coverage questions"
description: "Access and coverage questions on Ocrevus (ocrelizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Cost and coverage and Access support. Questions: Are Ocrevus and Ocrevus Zunovo covered by insurance? What are the J-codes for Ocrevus and Ocrevus Zunovo? Is the Ocrevus Zunovo price the same as Ocrevus IV? Is there an Ocrevus copay assistance program? 7 further questions follow. 11 questions quoted from 6 sources."
canonical: "https://www.evicenter.com/medical-information/ocrevus/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Ocrevus (ocrelizumab), all indications: Access and coverage questions

Manufacturer: Genentech, Inc.  
Prescribing information: [Ocrevus](https://www.gene.com/download/pdf/ocrevus_prescribing.pdf), [Ocrevus Zunovo](https://www.gene.com/download/pdf/ocrevus_zunovo_prescribing.pdf)  
Indication pages: [Multiple sclerosis](https://www.evicenter.com/medical-information/ocrevus--multiple-sclerosis)

## Cost and coverage

<a id="ocrevus-insurance-coverage"></a>

### Are Ocrevus and Ocrevus Zunovo covered by insurance?

> “95%
>
> of patients with multiple sclerosis (MS) have coverage for OCREVUS ZUNOVO”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=95%25,have%20coverage%20for%20OCREVUS%20ZUNOVO)

> “*Effective May 2025.”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=%2AEffective%20May%202025.)

> “Nationwide, OCREVUS [IV] is covered for over 96%, with the majority having unrestricted first-line access.<sup>†</sup>”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=Nationwide%2C%20OCREVUS%20%5BIV%5D%20is%20covered,the%20majority%20having%20unrestricted%20first%2Dline)

> “<sup>†</sup>Approximate national coverage for patients with relapsing MS. Formulary information and number of lives are provided by MMIT as of May 2025.”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=national%20coverage%20for%20patients%20with,MMIT%20as%20of%20May%202025.)

> “OCREVUS ZUNOVO has been covered for Medicare Fee-for-Service patients since launching on September 13, 2024”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=OCREVUS%20ZUNOVO%20has%20been%20covered,launching%20on%20September%2013%2C%202024)

> “85% of patients now covered for OCREVUS ZUNOVO<sup>║</sup>”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=85%25%20of%20patients%20now%20covered%20for%20OCREVUS)

> “<sup>║</sup>MMIT medical lives as of 2025. Individual plans may vary. This information is subject to change without notice.”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=medical%20lives%20as%20of%202025.,subject%20to%20change%20without%20notice.)

Note: The two pages of the site give different OCREVUS ZUNOVO coverage figures: 95% (effective May 2025) on the payer coverage page and 85% (MMIT medical lives as of 2025) on the access page. The pages state Medicare Fee-for-Service coverage for OCREVUS ZUNOVO only; the OCREVUS [IV] figure is for patients with relapsing MS.

<a id="ocrevus-j-code"></a>

### What are the J-codes for Ocrevus and Ocrevus Zunovo?

> “While OCREVUS ZUNOVO and OCREVUS [IV] use the same ICD-10-CM diagnosis codes, the drug-specific and administration coding is different.”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=While%20OCREVUS%20ZUNOVO%20and%20OCREVUS,and%20administration%20coding%20is%20different.)

> “Effective April 1, 2025: J2351* Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=Effective%20April%201%2C%202025%3A%20J2351%2A%20Injection%2C%20ocrelizumab%2C%201%20mg%20and%20hyaluronidase%2Docsq)

> “Drug: HCPCS
> J2350 
> Injection, ocrelizumab, 1 mg”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

> “Check your billable units on the claim: Generally, a 300-mg dose of OCREVUS [IV] is billed at 300 units  
> and a 600-mg dose of OCREVUS [IV] is billed at 600 units.”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

> “Check your billable units on the claim: Generally, a 920-mg dose of OCREVUS ZUNOVO is billed at 920 units.”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

> “The codes on pages 2 and 3 are not all-inclusive for multiple sclerosis; appropriate codes can vary by patient, setting of care and payer. Correct 
> coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special 
> billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or coverage for any item or service.”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

> “*These codes are not all-inclusive; appropriate codes can vary by patient, setting of care and payer. Correct coding is the responsibility of the provider submitting the claim for the item or service.”

Source: [OCREVUS: Coverage, captured 2026-11-12](https://www.ocrevus-hcp.com/access/payer-coverage.html#:~:text=%2AThese%20codes%20are%20not%20all%2Dinclusive%3B,for%20the%20item%20or%20service.)

Note: The J2350 code, the billable units, and the first disclaimer are from the example coding and billing document that the payer coverage page links.

<a id="ocrevus-price-vs-iv"></a>

### Is the Ocrevus Zunovo price the same as Ocrevus IV?

> “OCREVUS ZUNOVO is priced at annual wholesale acquisition cost (WAC) parity with OCREVUS [IV].”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=OCREVUS%20ZUNOVO%20is%20priced%20at,%28WAC%29%20parity%20with%20OCREVUS%20%5BIV%5D.)

> “OCREVUS ZUNOVO has the same specialty distributor and specialty pharmacy networks as OCREVUS [IV]”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=OCREVUS%20ZUNOVO%20has%20the%20same,pharmacy%20networks%20as%20OCREVUS%20%5BIV%5D)

> “Benefit type
> Mainly covered under the medical benefit”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=Benefit%20type,covered%20under%20the%20medical%20benefit)

<a id="ocrevus-copay-program"></a>

### Is there an Ocrevus copay assistance program?

> “With the OCREVUS Co-pay Program, eligible patients with commercial insurance could pay as little as $0 per treatment for OCREVUS or OCREVUS ZUNOVO. Co-pay assistance of up to $20,000 is provided per calendar year.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=With%20the%20OCREVUS%20Co%2Dpay%20Program%2C,is%20provided%20per%20calendar%20year.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “Your patient may be eligible if they:
>
> Have been prescribed OCREVUS or OCREVUS ZUNOVO for an FDA-approved indication
> Are 18 years of age or older, or have a caregiver or legally authorized person to manage the patient's co-pay assistance
>
> Have commercial (private or non-governmental) insurance. This includes plans available through state and federal health insurance exchanges
>
> Reside and receive treatment in the U.S. or U.S. Territories
>
> Are not receiving assistance through the Genentech Patient Foundation or any other charitable organization for the same expenses covered by the program
>
> Are not a government beneficiary and/or participant in a federal or state-funded health insurance program (e.g., Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD, TRICARE)”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=Your%20patient%20may%20be%20eligible,Medigap%2C%20Medicaid%2C%20VA%2C%20DoD%2C%20TRICARE%29)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

<a id="ocrevus-copay-cost"></a>

### How much do patients pay for Ocrevus with the copay program?

> “Help With Costs for OCREVUS or OCREVUS ZUNOVO”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=Help%20With%20Costs%20for%20OCREVUS%20or%20OCREVUS%20ZUNOVO)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “With the OCREVUS Co-pay Program, eligible patients with commercial insurance could pay as little as $0 per treatment for OCREVUS or OCREVUS ZUNOVO. Co-pay assistance of up to $20,000 is provided per calendar year.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=With%20the%20OCREVUS%20Co%2Dpay%20Program%2C,is%20provided%20per%20calendar%20year.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “Help With Costs for Drug Administration”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=Help%20With%20Costs%20for%20Drug%20Administration)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “With the OCREVUS Co-pay Program, eligible patients with commercial insurance could pay as little as $0 per OCREVUS or OCREVUS ZUNOVO drug administration. Co-pay assistance is provided up to $1,500 per calendar year in the first year and up to $1,000 each calendar year after.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=for%20Drug%20Administration-,With%20the%20OCREVUS%20Co%2Dpay%20Program%2C%20eligible%20patients%20with%20commercial%20insurance,%241%2C000%20each%20calendar%20year%20after.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “Do not reside or receive treatment in a restricted state (e.g. Massachusetts or Rhode Island)”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=Do%20not%20reside%20or%20receive,%28e.g.%20Massachusetts%20or%20Rhode%20Island%29)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “The total patient out-of-pocket cost is dependent on the patient’s health insurance plan.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=The%20total%20patient%20out%2Dof%2Dpocket%20cost,the%20patient%E2%80%99s%20health%20insurance%20plan.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “After reaching the maximum Programs’ benefit amounts, the patient will be responsible for all remaining out-of-pocket expenses.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=After%20reaching%20the%20maximum%20Programs%E2%80%99,for%20all%20remaining%20out%2Dof%2Dpocket%20expenses.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

Note: The restricted-state condition is one of the eligibility criteria listed for the drug administration benefit.

<a id="ocrevus-copay-medicare"></a>

### Can Medicare patients use the Ocrevus copay program?

> “The Product and Administration Co-pay Programs (“Programs”) are valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medicine. The Programs are not available to patients whose prescriptions are reimbursed under any federal, state, or government-funded insurance programs (included but not limited to Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs Programs) or where prohibited by law or by the patient's health insurance provider.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=The%20Product%20and%20Administration%20Co%2Dpay,the%20patient%27s%20health%20insurance%20provider.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

> “If at any time a patient begins receiving prescription drug coverage under any such federal, state or government-funded healthcare programs, the patient will no longer be eligible for the Programs.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=If%20at%20any%20time%20a,be%20eligible%20for%20the%20Programs.)

This passage is in a collapsed section of the page; select: OCREVUS Co-pay Program

<a id="ocrevus-foundations-medicare"></a>

### What copay help is available for Ocrevus patients with Medicare?

> “An independent co-pay assistance foundation is a charitable organization providing financial assistance to patients with specific disease states, regardless of treatment. Patients who are commercially or publicly insured, including those covered by Medicare and Medicaid, can contact the foundations directly to request assistance. Eligibility requirements, all aspects of the application process, turnaround times and the type or amount of assistance available (if any) can vary by foundation.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=An%20independent%20co%2Dpay%20assistance%20foundation,any%29%20can%20vary%20by%20foundation.)

On the page, select: Independent Co-pay Assistance Foundations

> “Independent co-pay assistance foundations have their own rules for eligibility. We have no involvement or influence in independent foundation decision-making or eligibility criteria and do not know if a foundation will be able to help your patient. We can only refer your patient to a foundation that supports their disease state. This information is provided as a resource for you. We do not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help your patient.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=Independent%20co%2Dpay%20assistance%20foundations%20have,might%20be%20able%20to%20help%20your%20patient.)

On the page, select: Independent Co-pay Assistance Foundations

<a id="ocrevus-patient-foundation"></a>

### Is there an Ocrevus patient assistance program for uninsured patients?

> “The Genentech Patient Foundation gives free OCREVUS or OCREVUS ZUNOVO to people who have been prescribed this medicine and don’t have insurance or that have financial concerns and meet certain eligibility criteria.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=The%20Genentech%20Patient%20Foundation%20gives,and%20meet%20certain%20eligibility%20criteria.)

This passage is in a collapsed section of the page; select: Genentech Patient Foundation

> “Your patient may be eligible if their insurance coverage and income match one of these situations:
>
> Uninsured patients with incomes under $150,000
> Insured patients without coverage for OCREVUS or OCREVUS ZUNOVO with incomes under $150,000
> Insured patients with coverage for a Genentech medicine:
> With an out-of-pocket maximum set by their health insurance plan that exceeds 7.5% of their household income
> With household size and income within certain guidelines”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=Your%20patient%20may%20be%20eligible%20if%20their,and%20income%20within%20certain%20guidelines)

This passage is in a collapsed section of the page; select: Genentech Patient Foundation

> “For any of these situations, add $25,000 for each extra person in households larger than 4 people.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=For%20any%20of%20these%20situations%2C,households%20larger%20than%204%20people.)

This passage is in a collapsed section of the page; select: Genentech Patient Foundation

> “We encourage insured patients to try other financial assistance options before applying for help from the Genentech Patient Foundation, if possible.”

Source: [OCREVUS: Financial Assistance Options, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/assistance-options.html#:~:text=We%20encourage%20insured%20patients%20to,Genentech%20Patient%20Foundation%2C%20if%20possible.)

This passage is in a collapsed section of the page; select: Genentech Patient Foundation

<a id="ocrevus-zunovo-starter-program"></a>

### Can patients get their first Ocrevus Zunovo dose free while coverage is pending?

> “Patients experiencing a payer coverage determination of >5 business days may be eligible to receive their first dose of OCREVUS ZUNOVO for free through the OCREVUS ZUNOVO Starter Program.”

Source: [OCREVUS: Support, captured 2026-11-12](https://www.ocrevus-hcp.com/access/support-programs.html#:~:text=Patients%20experiencing%20a%20payer%20coverage,the%20OCREVUS%20ZUNOVO%20Starter%20Program.)

> “Eligible patients can receive up to 1 dose of OCREVUS ZUNOVO Starter medicine. The patient is required to be new to OCREVUS products or been off of an OCREVUS product for at least 12 months.”

Source: [OCREVUS: Financial Support FAQs, captured 2026-11-12](https://www.ocrevus-hcp.com/financial-support/faqs.html#:~:text=Eligible%20patients%20can%20receive%20up,for%20at%20least%2012%20months.)

On the page, select: What is the OCREVUS ZUNOVO Starter Program?

> “Subject to eligibility requirements and terms and conditions. This program is void where prohibited by law and may not be used in or by residents of restricted states, if applicable.”

Source: [OCREVUS: Support, captured 2026-11-12](https://www.ocrevus-hcp.com/access/support-programs.html#:~:text=Subject%20to%20eligibility%20requirements%20and,of%20restricted%20states%2C%20if%20applicable.)

<a id="ocrevus-zunovo-samples"></a>

### Ocrevus Zunovo: are samples available to prescribers?

> “OCREVUS ZUNOVO samples are available”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=OCREVUS%20ZUNOVO%20samples%20are%20available)

> “OCREVUS ZUNOVO sample doses must be used according to the approved indications.”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=OCREVUS%20ZUNOVO%20sample%20doses%20must%20be%20used%20according%20to%20the%20approved%20indications.)

> “Annual sample limits per HCP and brand apply.”

Source: [OCREVUS: Access, captured 2026-11-12](https://www.ocrevus-hcp.com/access/incorporating-ocrevus.html#:~:text=Annual%20sample%20limits%20per%20HCP%20and%20brand%20apply.)

## Access support

<a id="ocrevus-patient-navigators"></a>

### Is there help with Ocrevus prior authorization and benefits investigation?

> “When your patient is enrolled in OCREVUS Access Solutions, a qualified Patient Navigator* will work with both of you throughout your journey with OCREVUS ZUNOVO or OCREVUS”

Source: [OCREVUS: Support, captured 2026-11-12](https://www.ocrevus-hcp.com/access/support-programs.html#:~:text=When%20your%20patient%20is%20enrolled,with%20OCREVUS%20ZUNOVO%20or%20OCREVUS)

> “Patient Navigators can help with:
>
> Enrollment
>
> Answer questions you or your patients may have throughout the enrollment process
>
> Benefits Investigations (BIs)
>
> Walk your patients through the results of their BI and help them understand next steps
>
> Treatment Coordination
>
> Provide treatment site options that work for your patient and their insurance
> Work with you and your patient to schedule treatments
> Walk your patient through a treatment checklist to help them prepare for treatment
>
> Patient Assistance
>
> Help identify potential financial and other assistance for eligible patients
>
> Prior Authorizations (PAs)
>
> Help you identify if a PA is necessary
> Offer resources as you obtain PAs for your patients
> Provide PA forms
>
> Automatic Benefits Reverification
>
> Reverify patients' benefits prior to their next scheduled treatment
> Coordinate with patients, practices and treatment sites (if applicable) to schedule the next treatment”

Source: [OCREVUS: Support, captured 2026-11-12](https://www.ocrevus-hcp.com/access/support-programs.html#:~:text=Patient%20Navigators%20can%20help%20with%3A,to%20schedule%20the%20next%20treatment)

> “The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and healthcare provider. Genentech makes no representation or guarantee concerning coverage or reimbursement for any service or item.”

Source: [OCREVUS: Support, captured 2026-11-12](https://www.ocrevus-hcp.com/access/support-programs.html#:~:text=The%20completion%20and%20submission%20of,for%20any%20service%20or%20item.)

> “*Patient Navigators are not healthcare professionals and cannot provide medical advice.”

Source: [OCREVUS: Support, captured 2026-11-12](https://www.ocrevus-hcp.com/access/support-programs.html#:~:text=%2APatient%20Navigators%20are%20not%20healthcare%20professionals%20and%20cannot%20provide%20medical%20advice.)

## Related pages
- [Medical information: Ocrevus (ocrelizumab): All indications](https://www.evicenter.com/medical-information/ocrevus)
- [Storage and supply](https://www.evicenter.com/medical-information/ocrevus/storage-and-supply)
